Results 171 to 180 of about 3,258,233 (341)
Toxicity of Excipients—A Food and Drug Administration Perspective [PDF]
Robert E. Osterberg, Norman A. See
openalex +1 more source
Organ‐on‐Chip (OoC) technology enables the precise modeling of the blood‐brain barrier (BBB). This study presents a microfluidic device that mimics brain microvessels, integrating co‐culture with pericytes and astrocytes under pulsatile flow. Results show that perivascular cells modulate endothelial morphology, promoting lumen formation and barrier ...
Vita Guarino+9 more
wiley +1 more source
A Rapid Systematic Review of U.S. Food and Drug Administration-Authorized COVID-19 Treatments. [PDF]
Maglione MA+10 more
europepmc +1 more source
Tobacco, the Food and Drug Administration, and Congress
Leonard H. Glantz, George J. Annas
openalex +2 more sources
A view from the field on food and drug administration regulation: report of a 2002 survey of U.S. fertility clinics [PDF]
Mark S. Frankel, Parisa Morris
openalex +1 more source
This paper presents a microphysiological system containing an array of individually addressable living corneal tissues constructed using primary human cells. The bioengineered eye model can simulate acute exposure of the human cornea to different types of environmental toxicants and provides a novel platform for visualization and quantitative ...
Se‐jeong Kim+12 more
wiley +1 more source
A Review of the Food and Drug Administration Pipeline and Proposed California Legislation on Medicinal Psychedelics. [PDF]
Watson JR+11 more
europepmc +1 more source
Industry Practices and Compliance with U.S. Food and Drug Administration Guidelines among California Sprout Firms [PDF]
Jennifer L. Thomas+4 more
openalex +1 more source